Oruka Therapeutics, Inc. (ORKA) SEC Filings — 2025
10 SEC filings for Oruka Therapeutics, Inc. (ORKA) in 2025.
Filings
- Oruka Therapeutics Files 8-K on Officer/Director Changes — 8-K · Dec 11, 2025
- ORKA's Losses Widen Amid Increased R&D, Bolstered by $180M PIPE — 10-Q · Nov 12, 2025
- Oruka Therapeutics Files 8-K: Material Agreement & Equity Sales — 8-K · Sep 22, 2025
- Oruka Therapeutics Reports No Revenue, Focuses on R&D — 10-Q · Aug 11, 2025
- Oruka Therapeutics Files 8-K on Officer/Director Changes — 8-K · Jul 1, 2025
- Oruka Therapeutics Files 8-K on Shareholder Vote Matters — 8-K · Jun 3, 2025
- Oruka Therapeutics Files Q1 2025 10-Q Report — 10-Q · May 14, 2025
- Oruka Therapeutics Files Proxy Statement for June Meeting — DEF 14A · Apr 18, 2025
- Oruka Therapeutics Files 2024 Annual Report — 10-K · Mar 6, 2025
- Oruka Therapeutics Enters Material Definitive Agreement — 8-K · Feb 5, 2025